Skip to content

Author

P. Lao

We have 3 of 208 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Multi-dimensional attention framework for personalised Alzheimer's disease progression prediction across sporadic and genetic risk cohorts

A multi-dimensional attention framework that simultaneously captures both temporal dynamics and biomarker importance to predict disease progression across three fundamentally different populations could enable precision medicine approaches for data-limited cohorts across the Alzheimer's disease spectrum.

Zhi-Yuan Song, Si-Yang Song, Isabel C. H. Clare et al. · 0 citations
Open access Jul 2026

Association of total and brain-derived Alzheimer's disease plasma biomarkers with brain amyloid deposition in a community-based sample

In a community-based sample, BD-p-tau217 emerged as the plasma biomarker most strongly associated with brain A{beta} deposition, although this association may be attenuated in the presence of moderate/severe kidney dysfunction or kidney failure.

Muge Akinci, Froogh Aziz, D. Guzman et al. · 0 citations
Open access Jul 2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

A double-cutoff analysis suggest that scans in the 11 to 26 Centiloid range should be interpreted with caution depending on the context of use, and positivity cutoffs converged around 18 Centiloids (data-driven) and 27 Centiloids (visual reads).

G. Blazhenets, D. Soleimani-Meigooni, Konstantinos Chiotis et al. · 5 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.